country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-106796

Copy Link Print Information

(-)-(S)-Bromofosfamide

Name: (-)-(S)-Bromofosfamide
Brand: MedChemExpress
SKU: HY-106796
Availability: PreOrder

(Synonyms: CBM 11)

(-)-(S)-Bromofosfamide (CBM 11) is an anti-cancer agent and a bromine-substituted IFO analog. (-)-(S)-Bromofosfamide can be studied in research on non-small cell lung cancer.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 146452-37-1
Formel: C₇H₁₅BrClN₂O₂P
Molecular Weight:305.54

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (267 KB)

(-)-(S)-Bromofosfamide Chemical Structure

CAS. Nr.: 146452-37-1

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität

Beschreibung

(-)-(S)-Bromofosfamide (CBM 11) is an anti-cancer agent and a bromine-substituted IFO analog. (-)-(S)-Bromofosfamide can be studied in research on non-small cell lung cancer^[1]^[2].

Chemical Information

CAS. Nr. 146452-37-1
Molecular Weight 305.54
Formel C₇H₁₅BrClN₂O₂P
SMILES

ClCCN[P@@]1(OCCCN1CCBr)=O
Synonyms

CBM 11
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (267 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Kobylińska, K., et al., (2001). Pharmacokinetics and toxicity of oral (-)-(S)-bromofosfamide in lung cancer patients. Arzneimittel-Forschung, 51(7), 600-603. [Content Brief]

[2]. Liang, J., et al., (2007). Design of new oxazaphosphorine anticancer drugs. Current pharmaceutical design, 13(9), 963-978. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen